SONOVA HOLDING AG-REG (PHBN.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:PHBN • CH0012549785

237.4 EUR
-1.6 (-0.67%)
Last: Jan 23, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PHBN. PHBN was compared to 68 industry peers in the Health Care Equipment & Supplies industry. PHBN scores excellent on profitability, but there are some minor concerns on its financial health. PHBN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year PHBN was profitable.
  • PHBN had a positive operating cash flow in the past year.
  • In the past 5 years PHBN has always been profitable.
  • Each year in the past 5 years PHBN had a positive operating cash flow.
PHBN.DE Yearly Net Income VS EBIT VS OCF VS FCFPHBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.45%, PHBN belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
  • PHBN has a Return On Equity of 21.44%. This is amongst the best in the industry. PHBN outperforms 89.06% of its industry peers.
  • PHBN has a Return On Invested Capital of 12.52%. This is amongst the best in the industry. PHBN outperforms 87.50% of its industry peers.
  • PHBN had an Average Return On Invested Capital over the past 3 years of 11.68%. This is above the industry average of 9.62%.
  • The 3 year average ROIC (11.68%) for PHBN is below the current ROIC(12.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.45%
ROE 21.44%
ROIC 12.52%
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
PHBN.DE Yearly ROA, ROE, ROICPHBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • PHBN's Profit Margin of 13.53% is fine compared to the rest of the industry. PHBN outperforms 79.69% of its industry peers.
  • In the last couple of years the Profit Margin of PHBN has declined.
  • PHBN has a better Operating Margin (19.28%) than 79.69% of its industry peers.
  • PHBN's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 71.66%, PHBN belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PHBN has remained more or less at the same level.
Industry RankSector Rank
OM 19.28%
PM (TTM) 13.53%
GM 71.66%
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
PHBN.DE Yearly Profit, Operating, Gross MarginsPHBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHBN is creating value.
  • The number of shares outstanding for PHBN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, PHBN has less shares outstanding
  • PHBN has a better debt/assets ratio than last year.
PHBN.DE Yearly Shares OutstandingPHBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PHBN.DE Yearly Total Debt VS Total AssetsPHBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 4.57 indicates that PHBN is not in any danger for bankruptcy at the moment.
  • PHBN's Altman-Z score of 4.57 is fine compared to the rest of the industry. PHBN outperforms 78.13% of its industry peers.
  • PHBN has a debt to FCF ratio of 2.11. This is a good value and a sign of high solvency as PHBN would need 2.11 years to pay back of all of its debts.
  • PHBN has a better Debt to FCF ratio (2.11) than 79.69% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that PHBN is somewhat dependend on debt financing.
  • PHBN has a Debt to Equity ratio of 0.58. This is in the lower half of the industry: PHBN underperforms 62.50% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for PHBN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.11
Altman-Z 4.57
ROIC/WACC2.77
WACC4.52%
PHBN.DE Yearly LT Debt VS Equity VS FCFPHBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • PHBN has a Current Ratio of 1.24. This is a normal value and indicates that PHBN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.24, PHBN is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
  • PHBN has a Quick Ratio of 1.24. This is a bad value and indicates that PHBN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of PHBN (0.91) is worse than 60.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.91
PHBN.DE Yearly Current Assets VS Current LiabilitesPHBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • PHBN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.93%.
  • Measured over the past 5 years, PHBN shows a small growth in Earnings Per Share. The EPS has been growing by 3.64% on average per year.
  • The Revenue has been growing slightly by 3.79% in the past year.
  • Measured over the past years, PHBN shows a small growth in Revenue. The Revenue has been growing by 5.79% on average per year.
EPS 1Y (TTM)-7.93%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-9.71%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%-0.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.43% on average over the next years. This is quite good.
  • PHBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.95% yearly.
EPS Next Y8.59%
EPS Next 2Y11.27%
EPS Next 3Y11.23%
EPS Next 5Y12.43%
Revenue Next Year1.7%
Revenue Next 2Y3.41%
Revenue Next 3Y4.16%
Revenue Next 5Y4.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PHBN.DE Yearly Revenue VS EstimatesPHBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
PHBN.DE Yearly EPS VS EstimatesPHBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • PHBN is valuated rather expensively with a Price/Earnings ratio of 24.96.
  • Based on the Price/Earnings ratio, PHBN is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, PHBN is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 19.40, the valuation of PHBN can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PHBN indicates a somewhat cheap valuation: PHBN is cheaper than 64.06% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. PHBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.96
Fwd PE 19.4
PHBN.DE Price Earnings VS Forward Price EarningsPHBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHBN indicates a somewhat cheap valuation: PHBN is cheaper than 64.06% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHBN indicates a rather cheap valuation: PHBN is cheaper than 84.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.43
EV/EBITDA 14.11
PHBN.DE Per share dataPHBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PHBN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.91
PEG (5Y)6.87
EPS Next 2Y11.27%
EPS Next 3Y11.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.09%, PHBN has a reasonable but not impressive dividend return.
  • PHBN's Dividend Yield is rather good when compared to the industry average which is at 1.03. PHBN pays more dividend than 81.25% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, PHBN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

  • On average, the dividend of PHBN grows each year by 7.88%, which is quite nice.
Dividend Growth(5Y)7.88%
Div Incr Years0
Div Non Decr Years0
PHBN.DE Yearly Dividends per sharePHBN.DE Yearly Dividends per shareYearly Dividends per share 2025 1 2 3 4

5.3 Sustainability

  • 50.40% of the earnings are spent on dividend by PHBN. This is a bit on the high side, but may be sustainable.
  • The dividend of PHBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50.4%
EPS Next 2Y11.27%
EPS Next 3Y11.23%
PHBN.DE Yearly Income VS Free CF VS DividendPHBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHBN.DE Dividend Payout.PHBN.DE Dividend Payout, showing the Payout Ratio.PHBN.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SONOVA HOLDING AG-REG

FRA:PHBN (1/23/2026, 7:00:00 PM)

237.4

-1.6 (-0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14
Earnings (Next)05-07
Inst Owners43%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap14.16B
Revenue(TTM)3.85B
Net Income(TTM)520.40M
Analysts53.33
Price Target278.88 (17.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend4.69
Dividend Growth(5Y)7.88%
DP50.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.61%
EPS NY rev (3m)-8.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 24.96
Fwd PE 19.4
P/S 3.37
P/FCF 18.43
P/OCF 15.81
P/B 5.34
P/tB N/A
EV/EBITDA 14.11
EPS(TTM)9.51
EY4.01%
EPS(NY)12.24
Fwd EY5.15%
FCF(TTM)12.88
FCFY5.43%
OCF(TTM)15.01
OCFY6.32%
SpS70.46
BVpS44.45
TBVpS-7.29
PEG (NY)2.91
PEG (5Y)6.87
Graham Number97.53
Profitability
Industry RankSector Rank
ROA 9.45%
ROE 21.44%
ROCE 17.78%
ROIC 12.52%
ROICexc 14.26%
ROICexgc 62.47%
OM 19.28%
PM (TTM) 13.53%
GM 71.66%
FCFM 18.28%
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
ROICexc(3y)13.28%
ROICexc(5y)13.73%
ROICexgc(3y)57.29%
ROICexgc(5y)71.13%
ROCE(3y)16.59%
ROCE(5y)16.07%
ROICexgc growth 3Y-12.61%
ROICexgc growth 5Y7.75%
ROICexc growth 3Y-3.74%
ROICexc growth 5Y4.49%
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.11
Debt/EBITDA 1.43
Cap/Depr 47.53%
Cap/Sales 3.02%
Interest Coverage 29.44
Cash Conversion 83.08%
Profit Quality 135.17%
Current Ratio 1.24
Quick Ratio 0.91
Altman-Z 4.57
F-Score7
WACC4.52%
ROIC/WACC2.77
Cap/Depr(3y)57.33%
Cap/Depr(5y)52.51%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.57%
Profit Quality(3y)107.52%
Profit Quality(5y)113.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-9.71%
EPS Next Y8.59%
EPS Next 2Y11.27%
EPS Next 3Y11.23%
EPS Next 5Y12.43%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%-0.97%
Revenue Next Year1.7%
Revenue Next 2Y3.41%
Revenue Next 3Y4.16%
Revenue Next 5Y4.95%
EBIT growth 1Y8.89%
EBIT growth 3Y-1.35%
EBIT growth 5Y8.03%
EBIT Next Year32.18%
EBIT Next 3Y15.32%
EBIT Next 5Y11.37%
FCF growth 1Y18.2%
FCF growth 3Y-7.7%
FCF growth 5Y-1.69%
OCF growth 1Y11.71%
OCF growth 3Y-5.52%
OCF growth 5Y-1.21%

SONOVA HOLDING AG-REG / PHBN.DE FAQ

Can you provide the ChartMill fundamental rating for SONOVA HOLDING AG-REG?

ChartMill assigns a fundamental rating of 6 / 10 to PHBN.DE.


Can you provide the valuation status for SONOVA HOLDING AG-REG?

ChartMill assigns a valuation rating of 5 / 10 to SONOVA HOLDING AG-REG (PHBN.DE). This can be considered as Fairly Valued.


What is the profitability of PHBN stock?

SONOVA HOLDING AG-REG (PHBN.DE) has a profitability rating of 8 / 10.


What is the valuation of SONOVA HOLDING AG-REG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SONOVA HOLDING AG-REG (PHBN.DE) is 24.96 and the Price/Book (PB) ratio is 5.34.


What is the earnings growth outlook for SONOVA HOLDING AG-REG?

The Earnings per Share (EPS) of SONOVA HOLDING AG-REG (PHBN.DE) is expected to grow by 8.59% in the next year.